DOTA-tetrazine probes with modified linkers for tumor pretargeting.

[1]  A. Kaloudi,et al.  Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. , 2017, Nuclear medicine and biology.

[2]  C. Bailly,et al.  Pretargeting for imaging and therapy in oncological nuclear medicine , 2017, EJNMMI Radiopharmacy and Chemistry.

[3]  Brian M Zeglis,et al.  Click Chemistry and Radiochemistry: The First 10 Years. , 2016, Bioconjugate chemistry.

[4]  Jason S. Lewis,et al.  Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry , 2016, Molecular Cancer Therapeutics.

[5]  C. Kuntner,et al.  Design, Synthesis, and Evaluation of a Low-Molecular-Weight (11)C-Labeled Tetrazine for Pretargeted PET Imaging Applying Bioorthogonal in Vivo Click Chemistry. , 2016, Bioconjugate chemistry.

[6]  T. Quinn,et al.  (99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging. , 2016, Bioorganic & medicinal chemistry.

[7]  Jason S. Lewis,et al.  Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses , 2016, The Journal of Nuclear Medicine.

[8]  A. Windhorst,et al.  A New Highly Reactive and Low Lipophilicity Fluorine-18 Labeled Tetrazine Derivative for Pretargeted PET Imaging. , 2016, ACS medicinal chemistry letters.

[9]  J. Valliant,et al.  (125)I-Tetrazines and Inverse-Electron-Demand Diels-Alder Chemistry: A Convenient Radioiodination Strategy for Biomolecule Labeling, Screening, and Biodistribution Studies. , 2016, Bioconjugate chemistry.

[10]  Jason S. Lewis,et al.  18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels–Alder Click Chemistry , 2015, Bioconjugate chemistry.

[11]  Jason S. Lewis,et al.  Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. , 2015, Molecular pharmaceutics.

[12]  I. E. Valverde,et al.  Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy. , 2015, Journal of medicinal chemistry.

[13]  Steven M. Larson,et al.  Radioimmunotherapy of human tumours , 2015, Nature Reviews Cancer.

[14]  W. Oyen,et al.  Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry , 2014, Front. Med..

[15]  C. Kuntner,et al.  Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging. , 2014, Angewandte Chemie.

[16]  R. Rossin,et al.  Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction. , 2014, Molecular pharmaceutics.

[17]  R. Rossin,et al.  Pretargeted imaging using bioorthogonal chemistry in mice. , 2014, Current opinion in chemical biology.

[18]  M. Kaliszczak,et al.  A bioorthogonal (68)Ga-labelling strategy for rapid in vivo imaging. , 2014, Chemical communications.

[19]  R. Laforest,et al.  Diels–Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody , 2013, The Journal of Nuclear Medicine.

[20]  R. Weissleder,et al.  A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry , 2013, The Journal of Nuclear Medicine.

[21]  C. Bodet-Milin,et al.  Improvement of Radioimmunotherapy Using Pretargeting , 2013, Front. Oncol..

[22]  R. Rossin,et al.  Highly reactive trans-cyclooctene tags with improved stability for Diels-Alder chemistry in living systems. , 2013, Bioconjugate chemistry.

[23]  G. Knudsen,et al.  Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation. , 2013, Chemical communications.

[24]  H. Janssen,et al.  Evaluation of strained alkynes for Cu-free click reaction in live mice. , 2013, Nuclear medicine and biology.

[25]  Greg M. Thurber,et al.  Reactive polymer enables efficient in vivo bioorthogonal chemistry , 2012, Proceedings of the National Academy of Sciences.

[26]  G. V. van Dongen,et al.  Synthesis of phosphine and antibody-azide probes for in vivo Staudinger ligation in a pretargeted imaging and therapy approach. , 2011, Bioconjugate chemistry.

[27]  K. Brindle,et al.  Imaging sialylated tumor cell glycans in vivo , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Ocak,et al.  Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607 , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  M. Ocak,et al.  Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative. , 2011, Nuclear medicine and biology.

[30]  R. Rossin,et al.  SYNFORM ISSUE 2010/9 , 2010, Angewandte Chemie.

[31]  J. Disselhorst,et al.  Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts , 2010, Molecular Cancer Therapeutics.

[32]  A. Nunn,et al.  In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites. , 2009, Bioconjugate chemistry.

[33]  D. Rizzieri,et al.  Radioimmunotherapy for Non-Hodgkin's Lymphoma. , 2005, Clinical medicine & research.

[34]  A. Eberle,et al.  Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  H. Saji,et al.  Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides. , 2001, Nuclear medicine and biology.

[36]  M. Charton,et al.  Substituent Effects on an Inverse Electron Demand Hetero Diels−Alder Reaction in Aqueous Solution and Organic Solvents: Cycloaddition of Substituted Styrenes to Di(2-pyridyl)-1,2,4,5-tetrazine , 1996 .

[37]  J. Verdú,et al.  Radioimmunotherapy for non-Hodgkin's lymphoma; positioning, safety, and efficacy of 90Y-Ibritumomab. 10 years of experience and follow-up. , 2017, Revista espanola de medicina nuclear e imagen molecular.

[38]  E. Krenning,et al.  Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting. , 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[39]  G. Paganelli,et al.  Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.